chloroquine/hydroxychloroquine |
inhibiting glycosylation of host receptors |
[38] |
azithromycin |
antibiotic/anti-inflammatory activities |
[39] |
lopinavir/ritonavir |
inactivation of the viral 3CL protease |
[40] |
ribavirin |
blocking RNA-dependent RNA polymerase |
[41] |
tocilizumab |
inhibition of IL-6 signaling |
[42] |
baricitinib/remdesivir |
blocking RNA-dependent RNA polymerase |
[43] |
favipiravir |
selective inhibition of viral RNA polymerase |
[44] |
abidol |
broad-spectrum antiviral compound |
[45] |
ruxolitinib |
competitively blocking the ATP-binding catalytic site on Janus kinases 1 and 2 |
[46] |
teicoplanin |
an antibiotic applied in the prophylaxis and therapy of bacterial infections caused by Gram-positive bacteria |
[47] |
ivermectin |
inhibition of the nuclear transport of viral proteins |
[48] |
corticosteroid |
immunosuppressive and anti-inflammatory activities |
[49] |
doxycycline |
blocking bacterial protein synthesis via binding to the 30S ribosomal subunit |
[50] |